Literature DB >> 8235667

Pulmonary alveolar hemorrhage in systemic lupus erythematosus.

E P Schwab1, H R Schumacher, B Freundlich, P E Callegari.   

Abstract

Pulmonary alveolar hemorrhage (PAH) is a rare and often fatal presenting feature of systemic lupus erythematosus (SLE). Reported mortality rates are extremely high, 70% to 90%. Death frequently occurs within the first several days of the hemorrhage. The hospital records of all inpatients with PAH and SLE between April 1986 and May 1991 at the Hospital of the University of Pennsylvania were reviewed. The complete resolution of PAH and the 75% survival rate found in this study is in marked contrast to previous reports. This experience suggests that patients with PAH and SLE may have a better prognosis than previously reported.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8235667     DOI: 10.1016/s0049-0172(05)80022-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  18 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

Review 2.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 3.  Vasculitis in systemic lupus erythematosus.

Authors:  L Barile-Fabris; M F Hernández-Cabrera; J A Barragan-Garfias
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

4.  Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus.

Authors:  Carlos Cañas; Gabriel J Tobón; Marcela Granados; Liliana Fernández
Journal:  Clin Rheumatol       Date:  2007-03-22       Impact factor: 2.980

5.  Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis.

Authors:  Motohide Isono; Hisazumi Araki; Takao Haitani; Yoshikata Morita; Mako Yasuda; Noriko Kato; Koji Urasaki; Yoshinori Tsujimura
Journal:  Clin Exp Nephrol       Date:  2011-01-12       Impact factor: 2.801

6.  Treatment of intractable pulmonary hemorrhage in two patients with childhood systemic lupus erythematosus.

Authors:  Mohammad Hassan Moradinejad
Journal:  Rheumatol Int       Date:  2009-04-07       Impact factor: 2.631

Review 7.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

8.  Diffuse alveolar hemorrhage: a rare life-threatening condition in systemic lupus erythematosus.

Authors:  Ravi Paul Singh Virdi; Adeel Bashir; Ghulamullah Shahzad; Javed Iqbal; Jose O Mejia
Journal:  Case Rep Pulmonol       Date:  2012-05-27

9.  Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane.

Authors:  Tolga T Barker; Pui Y Lee; Kindra M Kelly-Scumpia; Jason S Weinstein; Dina C Nacionales; Yutaro Kumagai; Shizuo Akira; Byron P Croker; Eric S Sobel; Westley H Reeves; Minoru Satoh
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

10.  Silica-associated systemic lupus erythematosus with lupus nephritis and lupus pneumonitis: A case report and a systematic review of the literature.

Authors:  Kazuhiko Fukushima; Haruhito A Uchida; Yasuko Fuchimoto; Tomoyo Mifune; Mayu Watanabe; Kenji Tsuji; Katsuyuki Tanabe; Masaru Kinomura; Shinji Kitamura; Yosuke Miyamoto; Sae Wada; Taisaku Koyanagi; Hitoshi Sugiyama; Takumi Kishimoto; Jun Wada
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.